Publicaciones en colaboración con investigadores/as de Brigham and Women's Hospital (17)

2017

  1. Complexity of complement resistance factors expressed by acinetobacter baumannii needed for survival in human serum

    Journal of Immunology, Vol. 199, Núm. 8, pp. 2803-2814

2014

  1. Alterations in the Staphylococcus epidermidis biofilm transcriptome following interaction with whole human blood

    Pathogens and Disease, Vol. 70, Núm. 3, pp. 444-448

2013

  1. Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, Núm. 24

2012

  1. Evaluation of the trimeric autotransporter ata as a vaccine candidate against Acinetobacter baumannii infections

    Infection and Immunity, Vol. 80, Núm. 10, pp. 3381-3388

  2. Identification of Ata, a multifunctional trimeric autotransporter of Acinetobacter baumannii

    Journal of Bacteriology, Vol. 194, Núm. 15, pp. 3950-3960

  3. Poly-n-acetyl-β-(1-6)-glucosamine is a target for protective immunity against acinetobacter baumannii infections

    Infection and Immunity, Vol. 80, Núm. 2, pp. 651-656

  4. Synthesis and Evaluation of a Conjugate Vaccine Composed of Staphylococcus aureus Poly-N-Acetyl-Glucosamine and Clumping Factor A

    PLoS ONE, Vol. 7, Núm. 9

2011

  1. Efficacy of a conjugate vaccine containing polymannuronic acid and flagellin against experimental Pseudomonas aeruginosa lung infection in mice

    Infection and Immunity, Vol. 79, Núm. 8, pp. 3455-3464

2010

  1. Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice

    Journal of Clinical Investigation, Vol. 120, Núm. 9, pp. 3220-3233

  2. Evaluation of flagella and flagellin of Pseudomonas aeruginosa as vaccines

    Infection and Immunity, Vol. 78, Núm. 2, pp. 746-755

  3. Synthetic β-(1→6)-linked N-acetylated and nonacetylated oligoglucosamines used to produce conjugate vaccines for bacterial pathogens

    Infection and Immunity, Vol. 78, Núm. 2, pp. 764-772

2008

  1. Wall teichoic acids are dispensable for anchoring the PNAG exopolysaccharide to the Staphylococcus aureus cell surface

    Microbiology, Vol. 154, Núm. 3, pp. 865-877

2007

  1. Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-β-(1-6)- glucosamine

    Infection and Immunity, Vol. 75, Núm. 7, pp. 3406-3413

  2. Protection against Escherichia coli infection by antibody to the Staphylococcus aureus poly-N-acetylglucosamine surface polysaccharide

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, Núm. 18, pp. 7528-7533

2005

  1. Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated staphylococcal poly-N-acetyl-β-(1-6)-glucosamine

    Infection and Immunity, Vol. 73, Núm. 10, pp. 6752-6762

  2. Poly-N-acetylglucosamine production in Staphylococcus aureus is essential for virulence in murine models of systemic infection

    Infection and Immunity, Vol. 73, Núm. 10, pp. 6868-6876

2004

  1. Biologic properties and vaccine potential of the staphylococcal poly-N-acetyl glucosamine surface polysaccharide

    Vaccine